Figure - PMC

Skip to main content

An official website of the United States government

Here's how you know

Here's how you know

Official websites use .gov
A .gov website belongs to an official government organization in the United States.

Secure .gov websites use HTTPS
A lock ( ) or https:// means you've safely connected to the .gov website. Share sensitive information only on official, secure websites.

View full-text article in PMC

. 2015 Dec 22;7(1):105–124. doi: 10.1007/s13300-015-0149-4

Search in PMC
Search in PubMed
View in NLM Catalog
Add to search

© The Author(s) 2015

This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/), which permits any noncommercial use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.

PMC Copyright notice

Fig. 2 — Kaplan–Meier curves for percentage of T2DM patients persistent to their therapy with GLP-1 receptor agonists. The figure describes percentage of T2DM still persistent (no gap >90 days) to their therapy with GLP-1 receptor agonists over time (12 months) with regards to UK-T2DM and GER-T2DM patients having started a therapy with GLP-1 receptor agonists. T2DM type 2 diabetes mellitus, GLP-1 glucagon-like peptide-1, UK United Kingdom, GER Germany